Home  >  Products  >  TRAF3IP2 (TRAF3 interacting protein 2) Blocking Peptide (the N terminal of TRAF3IP2)(100ug)
TRAF3IP2 (TRAF3 interacting protein 2) Blocking Peptide (the N terminal of TRAF3IP2)(100ug)

TRAF3IP2 (TRAF3 interacting protein 2) Blocking Peptide (the N terminal of TRAF3IP2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TRAF3IP2 Antibody (ARP52863_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP52863
Size: 100ug
Weight: 65kDa
Gene: 10758
Format: Lyophilized powder
Target: This gene encodes a protein involved in regulating responses to cytokines by members of the Rel/NF-kappaB transcription factor family. These factors play a central role in innate immunity in response to pathogens, inflammatory signals and stress. This gene product interacts with TRAF proteins (tumor necrosis factor receptor-associated factors) and either I-kappaB kinase or MAP kinase to activate either NF-kappaB or Jun kinase. Several alternative transcripts encoding different isoforms have been identified. Another transcript, which does not encode a protein and is transcribed in the opposite orientation, has been identified. Overexpression of this transcript has been shown to reduce expression of at least one of the protein encoding transcripts, suggesting it has a regulatory role in the expression of this gene.
Alternative names: ACT1; C6orf2; C6orf4; C6orf5; C6orf6; CIKS; DKFZp586G0522; MGC3581
See Full Product Listings >